Fluvastatin Sodium (Mylan Pharmaceuticals Inc.)
Welcome to the PulseAid listing for the Fluvastatin Sodium drug offered from Mylan Pharmaceuticals Inc.. This HMG-CoA Reductase Inhibitor [EPC],Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Mylan Pharmaceuticals Inc. |
NON-PROPRIETARY NAME: | fluvastatin |
SUBSTANCE NAME: | FLUVASTATIN SODIUM |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | HMG-CoA Reductase Inhibitor [EPC],Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET, FILM COATED, EXTENDED RELEASE |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2015-09-11 |
END MARKETING DATE: | 0000-00-00 |
Fluvastatin Sodium HUMAN PRESCRIPTION DRUG Details:
Item Description | Fluvastatin Sodium from Mylan Pharmaceuticals Inc. |
LABELER NAME: | Mylan Pharmaceuticals Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 80(mg/1) |
START MARKETING DATE: | 2015-09-11 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0378-5121_6c7ddc97-a8f0-4043-8176-f4b25572bf1f |
PRODUCT NDC: | 0378-5121 |
APPLICATION NUMBER: | ANDA202458 |
Other FLUVASTATIN SODIUM Pharmaceutical Manufacturers / Labelers: